Phase III study of vaccine candidate involved 43,538 participants
After Pfizer’s vaccine data, analysts say COVID drug makers face questions about long-term sales prospects esagonowsky Mon, 11/09/2020 […]
FDA reputation takes another hit after scathing aducanumab advisory panel meeting bbulik Mon, 11/09/2020 – 10:50
Ironwood names proxy brawler Denner to its board a year after R&D spinoff kblankenship Mon, 11/09/2020 – 09:51
Fierce Pharma Politics—Biden puts COVID-19 transition task force on the job esagonowsky Mon, 11/09/2020 – 09:15
GlaxoSmithKline’s HIV PrEP challenge looms as ViiV’s long-acting drug tops Gilead’s Truvada in women
GlaxoSmithKline’s HIV PrEP challenge looms as ViiV’s long-acting drug tops Gilead’s Truvada in women aliu Mon, 11/09/2020 – […]
Researchers at the University of Colorado Boulder are developing a wearable electronic device that’s “really wearable”- a stretchy […]
In the quest to image exceedingly small structures and phenomenon with higher precision, scientists have been pushing the […]
The Independent Scientific Advisory Group for Emergencies (Independent SAGE) has renewed its call for urgent reform of the […]
The NHS should vary the price it pays for cancer drugs depending on the disease they are used […]